Drugs / Platelet-Rich-Factor
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02349620 Comparator | Sep 2014 → Sep 2015 | — | Reza Tabrizi | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelet-Rich-Factor | “The main objective of this clinical trial study is to consider the effect of Platelet-Rich-Factor (PRF) on implant stability and marginal bone resorption around dental implants.” NCT02349620 ↗ |
| Known as | PRF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02349620 ↗ |